Newsgroups Main » Newsgroups Directory » Science and Technology » Medicine

Miscellaneous ( sci.med )

From [email protected] Sat Oct 10 05:54:41 1998 Path: news.isc.org!bounce-back From: [email protected] Newsgroups: news.announce.newgroups,news.groups,bionet.general,sci.med,sci.med.laboratory,sci.med.pathology,alt.support.hemophilia Subject: RFD: sci.med.diseases.blood Followup-To: news.groups Message-ID: <[email protected]> Approved: [email protected] Archive-Name: sci.med.diseases.blood Date: Fri, 09 Oct 1998 07:22:00 GMT Lines: 82 Xref: news.isc.org news.announce.newgroups:10612 news.groups:297962 sci.med:225188 sci.med.laboratory:5386 sci.med.pathology:6270                       REQUEST FOR DISCUSSION (RFD)                unmoderated group sci.med.diseases.blood  This is a formal Request for Discussion (RFD) for the creation of a worldwide, unmoderated Usenet newsgroup: sci.med.diseases.blood.  This is not a Call for Votes (CFV); you cannot vote at this time. Procedural details are below.  Newsgroup line: sci.med.diseases.blood	diseases of the blood.  RATIONALE: sci.med.diseases.blood  There are many different diseases that affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 600+ recipients and has a daily traffic of 10 to 20 postings. MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia. AltaVista and HotBot have been searched with the keywords of "blood" and "hematology" and no alternate newsgroups have been found.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER:  PROCEDURE:  This is a request for discussion, not a call for votes. In this phase of the process, any potential problems with the proposed newsgroup should be raised and resolved. The discussion period will continue for a minimum of 21 days (starting from when the first RFD for this proposal is posted to news.announce.newgroups), after which a Call for Votes (CFV) may be posted by a neutral vote taker if the discussion warrants it. Please do not attempt to vote until this happens.  All discussion of this proposal should be posted to news.groups.  This RFD attempts to comply fully with the Usenet newsgroup creation guidelines outlined in "How to Create a New Usenet Newsgroup" and "How to Format and Submit a New Group Proposal". Please refer to these documents (available in news.announce.newgroups) if you have any questions about the process.  DISTRIBUTION:  This RFD will be crossposted to the following newsgroups: news.announce.newgroups, news.groups,bionet.general, sci.med, sci.med.laboratory, sci.med.pathology, alt.support.hemophilia  and the following mailing list: mpd-support-l Subscribe by: Email to: [email protected] Subject line: Anything you want but not blank. Body: SUBSCRIBE MPD-SUPPORT-L  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]>  From [email protected] Fri Nov 20 01:00:40 1998 Path: news.isc.org!bounce-back From: Neil Crellin <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,alt.support.hemophilia,bionet.general,sci.med,sci.med.laboratory,sci.med.pathology Subject: CFV: sci.med.diseases.blood Followup-To: poster Message-ID: <[email protected]> References: <[email protected]> Organization: Usenet Volunteer Votetakers Approved: [email protected] Expires: 12 Dec 1998 00:00:00 GMT Archive-Name: sci.med.diseases.blood Date: Fri, 20 Nov 1998 08:50:09 GMT Lines: 145 Xref: news.isc.org news.announce.newgroups:10693 news.groups:301416 sci.med:227815 sci.med.laboratory:5607 sci.med.pathology:6428                       FIRST CALL FOR VOTES (of 2)                unmoderated group sci.med.diseases.blood  This CFV is to be distributed only by the votetaker.  It is not to be posted to newsgroups, or mailed to mailing lists or individuals, except by the votetaker.  Ballots or CFVs provided by anyone else will be invalid.  Newsgroups line: sci.med.diseases.blood	Information about any human blood diseases.  Votes must be received by 23:59:59 UTC, 11 Dec 1998.  This vote is being conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]> Votetaker: Neil Crellin <[email protected]>  RATIONALE: sci.med.diseases.blood  There are many different diseases that affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 600+ recipients and has a daily traffic of 10 to 20 postings. MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia and hemophilia. AltaVista and HotBot have been searched with the keywords of "blood" and "hematology" and no alternate newsgroups have been found.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER.  IMPORTANT VOTING PROCEDURE NOTES: READ THIS BEFORE VOTING  The purpose of a Usenet vote is to determine the genuine interest in reading the proposed newsgroup, and soliciting votes from uninterested parties defeats this purpose.  Do *not* distribute this CFV;  instead, direct people to the official CFV as posted to news.announce.newgroups. Distributing specific voting instructions or pre-marked copies of this CFV is considered vote fraud.  This is a public vote:  All email addresses, names and votes will be listed in the final RESULT post.  The name used may be either a real name or an established Usenet handle.  At most one vote is allowed per person or per account.  Duplicate votes will be resolved in favor of the most recent valid vote.  Voters must mail their ballots directly to the votetaker.  Anonymous, forwarded, or proxy votes are not valid, nor are votes mailed from WWW/HTML/CGI forms (which should not exist).  Votes from nonexistent accounts are also invalid, and the votetaker will reject any "munged" address he cannot decipher immediately.  Please direct any questions to the votetaker at <[email protected]>.  HOW TO VOTE:  Extract the ballot from the CFV by deleting everything before and after the "BEGINNING OF BALLOT" and "END OF BALLOT" lines.  Don't worry about the spacing of the columns or any quote characters (">") that your reply inserts.  Please, DO NOT send the entire CFV back to me!  Fill in the ballot as shown below.  Please provide your REAL NAME and indicate your desired vote in the appropriate locations inside the ballot.  Examples of how to properly indicate your vote:    [ YES     ]  example.yes.vote   [ NO      ]  example.no.vote   [ ABSTAIN ]  example.abstention   [ CANCEL  ]  example.cancellation  DO NOT modify, alter or delete any information in this ballot! If you do, the voting software will probably reject your ballot.  When finished, MAIL the ballot to: < [email protected] > Just "replying" to this message should work, but check the "To:" line.  If you do not receive an acknowledgment of your vote within three days contact the votetaker about the problem.  You are responsible for reading your ack and making sure your vote is registered correctly.  If these instructions are unclear, please consult the Introduction to Usenet Voting or the Usenet Voting FAQ at http://www.stanford.edu/~neilc/uvv.  ======== BEGINNING OF BALLOT: Delete everything before this line ======= .----------------------------------------------------------------------- | 1ST CALL FOR VOTES: sci.med.diseases.blood | Official Usenet Voting Ballot  (Do not remove this line!) |----------------------------------------------------------------------- | Please provide your real name, or your vote may be rejected.  Place | ONLY your name (ie. do NOT include your e-mail address or any other | information; ONLY your name) after the colon on the following line:  Voter name:  | Insert YES, NO, ABSTAIN, or CANCEL inside the brackets for each | newsgroup listed below (do not delete the newsgroup name):   Your Vote   Newsgroup  ---------   ----------------------------------------------------------- [         ]  sci.med.diseases.blood  ======== END OF BALLOT: Delete everything after this line ==============  DISTRIBUTION:  In addition to the groups named in the Newsgroups: header, the CFV and the eventual RESULT posts will be mailed to these mailing lists:  Mailing list name: mpd-support-l Submission address: [email protected] Request address: [email protected] ("subscribe mpd-support-l" in body)  This CFV was created with uvpq 1.0 (Aug 14 1997). PQ datestamp: 980322  --  Voting address: [email protected]  From [email protected] Tue Dec  1 13:00:59 1998 Path: news.isc.org!bounce-back From: Neil Crellin <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,alt.support.hemophilia,bionet.general,sci.med,sci.med.laboratory,sci.med.pathology Subject: 2nd CFV: sci.med.diseases.blood Followup-To: poster Message-ID: <[email protected]> References: <[email protected]> <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers Approved: [email protected] Expires: 12 Dec 1998 00:00:00 GMT Archive-Name: sci.med.diseases.blood Date: Tue, 01 Dec 1998 20:47:24 GMT Lines: 149 Xref: news.isc.org news.announce.newgroups:10721 news.groups:301950 sci.med:228394 sci.med.laboratory:5644 sci.med.pathology:6472                        LAST CALL FOR VOTES (of 2)                unmoderated group sci.med.diseases.blood  This CFV is to be distributed only by the votetaker.  It is not to be posted to newsgroups, or mailed to mailing lists or individuals, except by the votetaker.  Ballots or CFVs provided by anyone else will be invalid.  Newsgroups line: sci.med.diseases.blood	Information about any human blood diseases.  Votes must be received by 23:59:59 UTC, 11 Dec 1998.  This vote is being conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]> Votetaker: Neil Crellin <[email protected]>  RATIONALE: sci.med.diseases.blood  There are many different diseases that affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 600+ recipients and has a daily traffic of 10 to 20 postings. MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia and hemophilia. AltaVista and HotBot have been searched with the keywords of "blood" and "hematology" and no alternate newsgroups have been found.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER.  IMPORTANT VOTING PROCEDURE NOTES: READ THIS BEFORE VOTING  The purpose of a Usenet vote is to determine the genuine interest in reading the proposed newsgroup, and soliciting votes from uninterested parties defeats this purpose.  Do *not* distribute this CFV;  instead, direct people to the official CFV as posted to news.announce.newgroups. Distributing specific voting instructions or pre-marked copies of this CFV is considered vote fraud.  This is a public vote:  All email addresses, names and votes will be listed in the final RESULT post.  The name used may be either a real name or an established Usenet handle.  At most one vote is allowed per person or per account.  Duplicate votes will be resolved in favor of the most recent valid vote.  Voters must mail their ballots directly to the votetaker.  Anonymous, forwarded, or proxy votes are not valid, nor are votes mailed from WWW/HTML/CGI forms (which should not exist).  Votes from nonexistent accounts are also invalid, and the votetaker will reject any "munged" address he cannot decipher immediately.  Please direct any questions to the votetaker at <[email protected]>.  HOW TO VOTE:  Extract the ballot from the CFV by deleting everything before and after the "BEGINNING OF BALLOT" and "END OF BALLOT" lines.  Don't worry about the spacing of the columns or any quote characters (">") that your reply inserts.  Please, DO NOT send the entire CFV back to me!  Fill in the ballot as shown below.  Please provide your REAL NAME and indicate your desired vote in the appropriate locations inside the ballot.  Examples of how to properly indicate your vote:    [ YES     ]  example.yes.vote   [ NO      ]  example.no.vote   [ ABSTAIN ]  example.abstention   [ CANCEL  ]  example.cancellation  DO NOT modify, alter or delete any information in this ballot! If you do, the voting software will probably reject your ballot.  When finished, MAIL the ballot to: < [email protected] > Just "replying" to this message should work, but check the "To:" line.  If you do not receive an acknowledgment of your vote within three days contact the votetaker about the problem.  You are responsible for reading your ack and making sure your vote is registered correctly.  If these instructions are unclear, please consult the Introduction to Usenet Voting or the Usenet Voting FAQ at http://www.stanford.edu/~neilc/uvv.  ======== BEGINNING OF BALLOT: Delete everything before this line ======= .----------------------------------------------------------------------- | 2ND CALL FOR VOTES: sci.med.diseases.blood | Official Usenet Voting Ballot  (Do not remove this line!) |----------------------------------------------------------------------- | Please provide your real name, or your vote may be rejected.  Place | ONLY your name (ie. do NOT include your e-mail address or any other | information; ONLY your name) after the colon on the following line:  Voter name:  | Insert YES, NO, ABSTAIN, or CANCEL inside the brackets for each | newsgroup listed below (do not delete the newsgroup name):   Your Vote   Newsgroup  ---------   ----------------------------------------------------------- [         ]  sci.med.diseases.blood  ======== END OF BALLOT: Delete everything after this line ==============  DISTRIBUTION:  In addition to the groups named in the Newsgroups: header, the CFV and the eventual RESULT posts will be mailed to these mailing lists:  Mailing list name: mpd-support-l Submission address: [email protected] Request address: [email protected] ("subscribe mpd-support-l" in body)  sci.med.diseases.blood Bounce List - Please contact me about your vote ------------------------------------------------------------------------------- No bounced acknowledgments at this time  This CFV was created with uvpq 1.0 (Aug 14 1997). PQ datestamp: 980322  --  Voting address: [email protected]  From [email protected] Mon Dec 14 09:00:41 1998 Path: news.isc.org!bounce-back From: Neil Crellin <[email protected]> Newsgroups: news.announce.newgroups,news.groups,alt.support.hemophilia,bionet.general,sci.med,sci.med.laboratory,sci.med.pathology Subject: RESULT: sci.med.diseases.blood fails 65:9 Followup-To: news.groups Message-ID: <[email protected]> References: <[email protected]> <[email protected]> <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers Approved: [email protected] Archive-Name: sci.med.diseases.blood Date: Mon, 14 Dec 1998 16:51:32 GMT Lines: 167 Xref: news.isc.org news.announce.newgroups:10746 news.groups:302307 sci.med:229087 sci.med.laboratory:5690 sci.med.pathology:6502                                  RESULT          unmoderated group sci.med.diseases.blood fails 65:9  There were 65 YES votes and 9 NO votes, for a total of 74 valid votes.  There were 2 abstentions and 4 invalid ballots.  For a group to pass, YES votes must be at least 2/3 of all valid (YES and NO) votes.  There must also be at least 100 more YES votes than NO votes.  A five day discussion period follows this announcement.  Unless serious allegations of voting irregularities are raised, the group may not be voted on again for six months.  Newsgroups line: sci.med.diseases.blood	Information about any human blood diseases.  The voting period closed at 23:59:59 UTC, 11 Dec 1998.  This vote was conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]> Votetaker: Neil Crellin <[email protected]>  RATIONALE: sci.med.diseases.blood  There are many different diseases that affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 600+ recipients and has a daily traffic of 10 to 20 postings. MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia and hemophilia. AltaVista and HotBot have been searched with the keywords of "blood" and "hematology" and no alternate newsgroups have been found.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER.    sci.med.diseases.blood Final Voter list  Voted YES ------------------------------------------------------------------------------ aebagna [at] infovia.com.ar                                  Anibal Bagnarelli binnie [at] nor.com.au                                          Patten Headlam rridges [at] metz.une.edu.au                                    Rebecca Ridges dany.steyaert [at] ping.be                                       Dany Steyaert crleech [at] freenet.carleton.ca                                      C. Leech eg414 [at] freenet.carleton.ca                                    Tina M. Wood 3srf [at] qlink.queensu.ca                                      Steve Frampton jmcgarry [at] uoguelph.ca                                        James McGarry Bobbirobin [at] aol.com                                        Bobbi Rubenzahl Kathy944 [at] aol.com                                          Kathleen Ferris kimdv [at] best.com                                               Kim DeVaughn tigger [at] busprod.com                                 Dawni Summitt ~ tiggly jburrell [at] crl5.crl.com                                       Jason Burrell booda [at] datasync.com                                        Martin H. Booda david [at] farrar.com                                             David Farrar celticwiccan [at] hotmail.com                                      Peter Byron trofast [at] idirect.com                                         Ruth Freeburg ray32 [at] iname.com                                           Raymond Pastore kamlet [at] infinet.com                                             Art Kamlet ndallen [at] interlog.com                                          Nigel Allen Shel [at] k9ape.com                                         Sheldon L. Epstein GiesePa [at] kohlerco.com                                            Pat Giese mark [at] levymd.com                                        Mark I. Levy, M.D. wilcox [at] localnet.com                                        Maynard Wilcox rasanen [at] email.msn.com                                             rasanen sleeper54 [at] my-dejanews.com                                        t w hess uthman [at] neosoft.com                                              Ed Uthman abaker1 [at] ix.netcom.com                          Natalie Thomas gselt [at] ix.netcom.com                                          Gregg Selton salazar [at] ix.netcom.com                                    Susan E. Salazar chriseb [at] nortelnetworks.com                                 Chris Ebenezer jepace [at] pobox.com                                               James Pace mph [at] pobox.com                                                Matthew Hunt pan [at] syix.com                                                          Pan arielle [at] Taronga.COM                                    Stephanie da Silva doug.obrien [at] the-spa.com                                             D.O'B wmhblair [at] verio.com                                       William H. Blair dale [at] wco.com                                               Dale M. Tersey xanthian [at] well.com                                         Kent Paul Dolan vote [at] kholdan.snafu.de                                         tobias erle bouvin [at] daimi.au.dk                                      Niels Olof Bouvin pmosbach [at] bu.edu                                             Peter Mosbach rick [at] bcm.tmc.edu                                           Richard Miller enge0213 [at] tc.umn.edu                                       Aaron Engelhart rufinus [at] mbe.ece.wisc.edu                                        J Rufinus tajima [at] med.teikyo-u.ac.jp                                    Yasuo Tajima ccsr [at] capecod.net                                             Anne Harding roses [at] capecod.net                                  DOLORES SCALDINI KLIMM jwclark [at] cgocable.net                                           John Clark ellis [at] ftel.net                                                 Rick Ellis lanzyg [at] ibm.net                                           Garrett R. Lanzy kiminy [at] couriernet.infi.net                                    Pete Womack jcrouch [at] Mcs.Net                                               Jude Crouch tc [at] Mcs.Net                                                    Thomas Cuny jonboy [at] onlink.net                                          Trevor Tymchuk wakelyn [at] pinn.net                                            N. T. Wakelyn pmeyer [at] prodigy.net                                           Pamela Meyer beckman [at] srv.net                                           Barbara Beckman arjanh [at] cs.vu.nl                                            Arjan Hulsebos finn [at] nasw.org                                                 Robert Finn helen_b_sg [at] mtu-net.ru                                     Elena Boldyreva ajtr2 [at] cam.ac.uk                                                  Alex Ray merlin [at] cvnet.co.uk                                            Darren Rees marks [at] microlise.co.uk                                          Mark Snape risalaz [at] ci.long-beach.ca.us                                  Rick Salazar  Voted NO ------------------------------------------------------------------------------ JCSMJS [at] aol.com                                                Jerry Smith stainles [at] bga.com                                             Dwight Brown cipher [at] mindspring.com                                              Cipher olav [at] viking.mv.com                                        Olav Nieuwejaar sproing [at] my-dejanews.com                                        Herb Petro daver [at] teleport.com                                             D Reynolds naddy [at] mips.rhein-neckar.de                           Christian Weisgerber albe [at] lvs.informatik.RWTH-Aachen.DE                         Alexander Bell simon [at] darkmere.gen.nz                                         Simon Lyall  Abstained ------------------------------------------------------------------------------ guymacon [at] deltanet.com                   [email protected] (Guy Macon) chris [at] kzim.com                                Christopher Robin Zimmerman  Invalid votes ------------------------------------------------------------------------------ SANHOFF [at] aol.com     ! No vote statement in message meascarrunz                                        Maria Eugenia Ascarrunz
     ! Invalid address gail [at] airmail.net                                      Juana Gail Springer     ! No vote statement in message rseibert [at] microdsi.net                                            rseibert     ! No vote statement in message   --  Neil Crellin, UVV <[email protected]>  From [email protected] Sun Sep 26 21:27:34 1999 Path: news.isc.org!bounce-back From: <[email protected]> Newsgroups: news.announce.newgroups,news.groups,bionet.general,sci.med,sci.med.laboratory,sci.med.pathology,alt.support.hemophilia Subject: RFD: sci.med.diseases.blood Followup-To: news.groups Message-ID: <[email protected]> Approved: [email protected] Archive-Name: sci.med.diseases.blood Date: Mon, 27 Sep 1999 04:27:44 GMT Lines: 83 Xref: news.isc.org news.announce.newgroups:11155 news.groups:4448+87 sci.med:250450 sci.med.laboratory:8492 sci.med.pathology:7726                       REQUEST FOR DISCUSSION (RFD)                unmoderated group sci.med.diseases.blood  This is a formal Request for Discussion (RFD) for the creation of a worldwide, unmoderated Usenet newsgroup: sci.med.diseases.blood.  This is not a Call for Votes (CFV); you cannot vote at this time. Procedural details are below.  Newsgroup line: sci.med.diseases.blood	diseases of the blood.  RATIONALE: sci.med.diseases.blood  There are many different diseases that affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 600+ recipients and has a daily traffic of 10 to 20 postings. MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia. AltaVista and HotBot have been searched with the keywords of "blood" and "hematology" and no alternate newsgroups have been found.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER:  PROCEDURE:  This is a request for discussion, not a call for votes. In this phase of the process, any potential problems with the proposed newsgroup should be raised and resolved. The discussion period will continue for a minimum of 21 days (starting from when the first RFD for this proposal is posted to news.announce.newgroups), after which a Call for Votes (CFV) may be posted by a neutral vote taker if the discussion warrants it. Please do not attempt to vote until this happens.  All discussion of this proposal should be posted to news.groups.  This RFD attempts to comply fully with the Usenet newsgroup creation guidelines outlined in "How to Create a New Usenet Newsgroup" and "How to Format and Submit a New Group Proposal". Please refer to these documents (available in news.announce.newgroups) if you have any questions about the process.  DISTRIBUTION:  This RFD will be crossposted to the following newsgroups: news.announce.newgroups, news.groups,bionet.general, sci.med, sci.med.laboratory, sci.med.pathology, alt.support.hemophilia  and the following mailing list: mpd-support-l Subscribe by: Email to: [email protected] Subject line: Anything you want but not blank. Body: SUBSCRIBE MPD-SUPPORT-L  Proponent: Robert Tollen <[email protected]>  Mentor: Richard Miller <[email protected]>  From [email protected] Thu Oct 21 02:12:41 1999 Path: news.isc.org!bounce-back From: [email protected] Newsgroups: news.announce.newgroups,news.groups,bionet.general,sci.med,sci.med.laboratory,sci.med.pathology,alt.support.hemophilia,sci.med.diseases.cancer Subject: 2nd RFD: sci.med.diseases.blood Followup-To: news.groups Message-ID: <[email protected]> Approved: [email protected] Archive-Name: sci.med.diseases.blood Date: Thu, 21 Oct 1999 09:02:18 GMT Lines: 94 Xref: news.isc.org news.announce.newgroups:11178 news.groups:330755 sci.med:251974 sci.med.laboratory:8768 sci.med.pathology:7872 sci.med.diseases.cancer:36067                       REQUEST FOR DISCUSSION (RFD)                unmoderated group sci.med.diseases.blood  This is a formal Request for Discussion (RFD) for the creation of a worldwide, unmoderated Usenet newsgroup: sci.med.diseases.blood.  This is not a Call for Votes (CFV); you cannot vote at this time. Procedural details are below.  Newsgroup line: sci.med.diseases.blood	diseases of the blood.  CHANGES from previous RFD:  Rationale expanded.  RATIONALE: sci.med.diseases.blood  Many different diseases affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 800+ recipients and has a daily traffic of 10 to 20 postings. All postings can be seen at http://listserv.aol.com/archives/mpd-support-l.html. MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia. The WWW.DEJANEWS.COM HEALTH and FITNESS discussions have been searched with the keywords of "blood and  diseases" and no alternate newsgroups were found to exist. Shared information on treatment of blood diseases is important to participants because in many instances there is a wide variety of treatments for the same disease.  The grave seriousness of most questions and replies significantly outweigh any fluctuation in daily traffic. Blood diseases are so complicated that a newly diagnosed patient deserves support and facts, no matter how rare the disease.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER:  PROCEDURE:  This is a request for discussion, not a call for votes. In this phase of the process, any potential problems with the proposed newsgroup should be raised and resolved. The discussion period will continue for a minimum of 21 days (starting from when the first RFD for this proposal is posted to news.announce.newgroups), after which a Call for Votes (CFV) may be posted by a neutral vote taker if the discussion warrants it. Please do not attempt to vote until this happens.  All discussion of this proposal should be posted to news.groups.  This RFD attempts to comply fully with the Usenet newsgroup creation guidelines outlined in "How to Create a New Usenet Newsgroup" and "How to Format and Submit a New Group Proposal". Please refer to these documents (available in news.announce.newgroups) if you have any questions about the process.  DISTRIBUTION:  This RFD will be crossposted to the following newsgroups: news.announce.newgroups, news.groups,bionet.general, sci.med, sci.med.laboratory, sci.med.pathology, alt.support.hemophilia, sci.med.diseases.blood  and the following mailing list: mpd-support-l Subscribe by: Email to: [email protected] Subject line: Anything you want but not blank. Body: SUBSCRIBE MPD-SUPPORT-L  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]>  From [email protected] Mon Jan  3 15:30:07 2000 Path: news.isc.org!bounce-back From: Jim Davis <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,alt.support.hemophilia,bionet.general,sci.med,sci.med.laboratory,sci.med.diseases.cancer,sci.med.pathology Subject: CFV: sci.med.diseases.blood Followup-To: poster Message-ID: <[email protected]> Organization: Usenet Volunteer Votetakers (counting votes so you don't have to) Approved: [email protected] Expires: 25 Jan 2000 00:00:00 GMT Archive-Name: sci.med.diseases.blood Date: Mon, 03 Jan 2000 23:15:21 GMT Lines: 130 Xref: news.isc.org news.announce.newgroups:11277 news.groups:339381 sci.med:255481 sci.med.laboratory:9426 sci.med.diseases.cancer:37796 sci.med.pathology:8099                       FIRST CALL FOR VOTES (of 2)                unmoderated group sci.med.diseases.blood  Newsgroups line: sci.med.diseases.blood	Information about any human blood diseases.  Votes must be received by 23:59:59 UTC, 24 Jan 2000.  This vote is being conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]> Votetaker: Jim Davis <[email protected]>  RATIONALE: sci.med.diseases.blood  Many different diseases affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 800+ recipients and has a daily traffic of 10 to 40 postings. All postings can be seen at http://listserv.aol.com/archives/mpd-support-l.html MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia. The WWW.DEJANEWS.COM HEALTH and FITNESS discussions have been searched with the keywords of "blood and  diseases" and no alternate newsgroups were found to exist. Shared information on treatment of blood diseases is important to participants because in many instances there is a wide variety of treatments for the same disease.  The grave seriousness of most questions and replies significantly outweigh any fluctuation in daily traffic. Blood diseases are so complicated that a newly diagnosed patient deserves support and facts, no matter how rare the disease.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER.  HOW TO VOTE:  Extract the ballot from the CFV by deleting everything before and after the "-=-=-=-" lines.  Don't worry about the spacing of the columns or any quote characters (">") that your reply inserts.  And please don't send the entire CFV back!  Mark the ballot and then mail it to: [email protected]  Examples of how to properly indicate your vote:  [ YES     ]  example.yes.vote [ NO      ]  example.no.vote [ ABSTAIN ]  example.abstention [ CANCEL  ]  example.cancellation  -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=- sci.med.diseases.blood Ballot     (Don't remove this marker)  Give your real name here:    Your Vote  Newsgroup ----------------------------------------------------------------------- [         ]  sci.med.diseases.blood -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=-  If these instructions are unclear, please consult the Introduction to Usenet Voting or the Usenet Voting FAQ at http://www.iki.fi/~jpatokal/uvv/.  DISTRIBUTION:  A pointer directing readers to the CFV will be posted to this mailing list:  Mailing list name: Myeloproliferative Disease Support List Submission address: [email protected] Request address (optional): [email protected]  IMPORTANT VOTING PROCEDURE NOTES:  Standard Guidelines for voting apply.  One vote per person, one account per voter.  Votes must be mailed directly from the voter to the votetaker. Anonymous, forwarded or proxy votes are not valid.  Votes mailed by WWW/HTML/CGI forms are considered to be anonymous votes.  Vote counting is automated.  Failure to follow these directions may mean that your vote does not get counted.  If you do not receive an acknowledgment of your vote within three days contact the votetaker about the problem.  It's your responsibility to make sure your vote is registered correctly.  Duplicate votes are resolved in favor of the most recent valid vote.  Addresses and votes of all voters will be published in the final voting results post.  The purpose of a Usenet vote is to determine the genuine interest of persons who would read a proposed newsgroup.  Soliciting votes from disinterested parties defeats this purpose.  Please do not distribute this CFV.  If you must, direct people to the official CFV as posted to news.announce.newgroups.  Distributing pre-marked or otherwise edited copies of this CFV is generally considered to be vote fraud. When in doubt, ask the votetaker.   This CFV was created with uvpq 1.0 (Jun 10 1997). PQ datestamp: 980322   --  Jim Davis        | "Plaaay NICE!!" [email protected] |   -- Bubbles  From [email protected] Thu Jan 13 09:26:40 2000 Path: news.isc.org!bounce-back From: Jim Davis <[email protected]> Reply-To: [email protected] Newsgroups: news.announce.newgroups,news.groups,alt.support.hemophilia,bionet.general,sci.med,sci.med.laboratory,sci.med.diseases.cancer,sci.med.pathology Subject: 2nd CFV: sci.med.diseases.blood Followup-To: poster Message-ID: <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers (counting votes so you don't have to) Approved: [email protected] Expires: 25 Jan 2000 00:00:00 GMT Archive-Name: sci.med.diseases.blood Date: Thu, 13 Jan 2000 17:29:36 GMT Lines: 134 Xref: news.isc.org news.announce.newgroups:11289 news.groups:340267 sci.med:256062 sci.med.laboratory:9514 sci.med.diseases.cancer:38240 sci.med.pathology:8134                        LAST CALL FOR VOTES (of 2)                unmoderated group sci.med.diseases.blood  Newsgroups line: sci.med.diseases.blood	Information about any human blood diseases.  Votes must be received by 23:59:59 UTC, 24 Jan 2000.  This vote is being conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]> Votetaker: Jim Davis <[email protected]>  RATIONALE: sci.med.diseases.blood  Many different diseases affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 800+ recipients and has a daily traffic of 10 to 40 postings. All postings can be seen at http://listserv.aol.com/archives/mpd-support-l.html MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia. The WWW.DEJANEWS.COM HEALTH and FITNESS discussions have been searched with the keywords of "blood and  diseases" and no alternate newsgroups were found to exist. Shared information on treatment of blood diseases is important to participants because in many instances there is a wide variety of treatments for the same disease.  The grave seriousness of most questions and replies significantly outweigh any fluctuation in daily traffic. Blood diseases are so complicated that a newly diagnosed patient deserves support and facts, no matter how rare the disease.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER.  HOW TO VOTE:  Extract the ballot from the CFV by deleting everything before and after the "-=-=-=-" lines.  Don't worry about the spacing of the columns or any quote characters (">") that your reply inserts.  And please don't send the entire CFV back!  Mark the ballot and then mail it to: [email protected]  Examples of how to properly indicate your vote:  [ YES     ]  example.yes.vote [ NO      ]  example.no.vote [ ABSTAIN ]  example.abstention [ CANCEL  ]  example.cancellation  -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=- sci.med.diseases.blood Ballot     (Don't remove this marker)  Give your real name here:    Your Vote  Newsgroup ----------------------------------------------------------------------- [         ]  sci.med.diseases.blood -=-=-=-=-=- Don't Delete Anything Between These Lines =-=-=-=-=-=-=-=-  If these instructions are unclear, please consult the Introduction to Usenet Voting or the Usenet Voting FAQ at http://www.iki.fi/~jpatokal/uvv/.  DISTRIBUTION:  A pointer directing readers to the CFV will be posted to this mailing list:  Mailing list name: Myeloproliferative Disease Support List Submission address: [email protected] Request address (optional): [email protected]  IMPORTANT VOTING PROCEDURE NOTES:  Standard Guidelines for voting apply.  One vote per person, one account per voter.  Votes must be mailed directly from the voter to the votetaker. Anonymous, forwarded or proxy votes are not valid.  Votes mailed by WWW/HTML/CGI forms are considered to be anonymous votes.  Vote counting is automated.  Failure to follow these directions may mean that your vote does not get counted.  If you do not receive an acknowledgment of your vote within three days contact the votetaker about the problem.  It's your responsibility to make sure your vote is registered correctly.  Duplicate votes are resolved in favor of the most recent valid vote.  Addresses and votes of all voters will be published in the final voting results post.  The purpose of a Usenet vote is to determine the genuine interest of persons who would read a proposed newsgroup.  Soliciting votes from disinterested parties defeats this purpose.  Please do not distribute this CFV.  If you must, direct people to the official CFV as posted to news.announce.newgroups.  Distributing pre-marked or otherwise edited copies of this CFV is generally considered to be vote fraud. When in doubt, ask the votetaker.   This CFV was created with uvpq 1.0 (Jun 10 1997). PQ datestamp: 980322  sci.med.diseases.blood Bounce List - Please contact me about your vote: ------------------------------------------------------------------------------ [email protected]                                        Rick Salazar   --  Jim Davis        | "Plaaay NICE!!" [email protected] |   -- Bubbles  From [email protected] Tue Jan 25 15:41:26 2000 Path: news.isc.org!bounce-back From: Jim Davis <[email protected]> Newsgroups: news.announce.newgroups,news.groups,alt.support.hemophilia,bionet.general,sci.med,sci.med.laboratory,sci.med.diseases.cancer,sci.med.pathology Subject: RESULT: sci.med.diseases.blood fails 78:7 Followup-To: news.groups Message-ID: <[email protected]> Supersedes: <[email protected]> Organization: Usenet Volunteer Votetakers (counting votes so you don't have to) Approved: [email protected] Archive-Name: sci.med.diseases.blood Date: Tue, 25 Jan 2000 23:36:07 GMT Lines: 182 Xref: news.isc.org news.announce.newgroups:11311 news.groups:341340 sci.med:256620 sci.med.laboratory:9673 sci.med.diseases.cancer:38495 sci.med.pathology:8173                                  RESULT          unmoderated group sci.med.diseases.blood fails 78:7  There were 78 YES votes and 7 NO votes, for a total of 85 valid votes.  There were 5 abstains.  There were 13 invalidated ballots.  For group passage, YES votes must be at least 2/3 of all valid (YES and NO) votes.   There also must be at least 100 more YES votes than NO votes.  There is a five day discussion period after these results are posted. Unless serious allegations of voting irregularities are raised, the group may not be voted on again for six months.   Newsgroups line: sci.med.diseases.blood	Information about any human blood diseases.  This vote was conducted by a neutral third party.  Questions about the proposed group should be directed to the proponent.  Proponent: Robert Tollen <[email protected]> Mentor: Richard Miller <[email protected]> Votetaker: Jim Davis <[email protected]>  RATIONALE: sci.med.diseases.blood  Many different diseases affect blood. In the United States alone approximately 72,000 people have sickle cell anemia with about 2,000,000 carrying the trait. There are 20,000 hemophilia patients in the U.S. Each year, nearly 27,000 adults and more than 2,000 children in the United States learn that they have leukemia (statistics are from NIH and Cancernet web sites). There is now a listserv named MPD-SUPPORT-L which has 800+ recipients and has a daily traffic of 10 to 40 postings. All postings can be seen at http://listserv.aol.com/archives/mpd-support-l.html MPD stands for Myelo Proliferative Disorders, which are diseases of the blood. The myeloproliferative disorders include polycythemia vera (PV), chronic myelogenous leukemia, agnogenic myeloid metaplasia, and essential thrombocythemia (ET). This newsgroup will include these plus all other diseases of the blood including sickle cell anemia. The WWW.DEJANEWS.COM HEALTH and FITNESS discussions have been searched with the keywords of "blood and  diseases" and no alternate newsgroups were found to exist. Shared information on treatment of blood diseases is important to participants because in many instances there is a wide variety of treatments for the same disease.  The grave seriousness of most questions and replies significantly outweigh any fluctuation in daily traffic. Blood diseases are so complicated that a newly diagnosed patient deserves support and facts, no matter how rare the disease.  CHARTER: sci.med.diseases.blood  Many people have some form of blood disease, either detected or not. The purpose of this newsgroup is to establish electronic media for communication between patients, scientists and any other individuals with interest in diseases of the blood. Such communications will provide quick and effective means to exchange information and knowledge, offer encouragement, and solve problems.  The sci.med.diseases.blood newsgroup will target participants who are afflicted with any blood disorder. Doctors, researchers, students or anyone with interest in diseases of the blood will also be welcome.  A FAQ for new users will be posted on a regular basis.  No binary posts will be allowed.  No advertisements will be allowed.  END CHARTER.  VOTETAKER'S NOTE:  13 ballots were received from mia-cs52-001-vty67.as.wcom.net [209.154.12.67] between 08:06 and 08:36 on 20 January, claiming to be from a variety of different addresses and, curiously, all with the real names typed entirely in lower case.  sci.med.diseases.blood Final Vote Ack -- this is not a mailing list!  Voted Yes ------------------------------------------------------------------------------ alex.dawson = uea.ac.uk                                            Alex Dawson ascott ]/ pacifier.com                                           Alan P. Scott bill_supon (<$| yahoo.com                                             W. Supon bogie {)~] xs4all.nl                                       Boudewijn van Ingen bouvin & daimi.au.dk                                         Niels Olof Bouvin buff )#` pobox.com                                              William Denton carlson {, ironbridgenetworks.com                                James Carlson ceichler _^> enteract.com                                      Charles Eichler chriseb =(_] nortelnetworks.com                                 Chris Ebenezer cpl1 &=] hades.uchicago.edu                                         Corey Liss david {+, farrar.com                                              David Farrar davidsen # tmr.com                                               bill davidsen djb }|/] v2000.scream.org                                         Dan Birchall doc _+^ america.net                                                  Rob Wynne dougob ^&){ the-spa.com                                           Dave O'Brien edward =]#> paleo.org                                              Edward Reid eg414 (~ freenet.carleton.ca                                      Tina M. Wood Ekkehard.Uthke ] gmx.de                                         Ekkehard Uthke ellis =~) ftel.net                                                  Rick Ellis eridani $} databasix.com                                               Belinda evert *{[# royal.net                                              Evert Meulie finn ` nasw.org                                                    Robert Finn fogazzid ^ softhome.net                                        Daniele Fogazzi fran_keeling -)[+ my-deja.com                                  Frances Keeling fyr+news ]<)~ nabab.teaser.fr                                 Francois RANCHIN gardener _ mail.ocis.net                                            Ann Hughes gheston } mail.HiWAAY.net                                       Gary L. Heston h.slama , gmx.net                                               Heribert Slama hfung $# CSUPomona.Edu                                               Hank Fung ianatasm #$ netcomuk.co.uk                                           Ian Baird ianlivesey { beeb.net                                              ian livesey IgoneKrazy >(&| aol.com                                           Julie Refkin jcrouch = enteract.com                                             Jude Crouch jmcgarry _=> uoguelph.ca                                         James McGarry John_David_Galt ]|&# acm.org                                   John David Galt jolomo / netcom.com                                                 Joe Morris julesd &]{` erols.com                                             Jules Dubois jwootton `, home.com                                              Jean Wootton kamlet *((^ infinet.com                                          Arthur Kamlet kb5cng ($ amsat.org                                           R.L. Bo Thompson kennedy ( eninet.eas.asu.edu                                  Ralph D. Kennedy kimdv & best.com                                                  Kim DeVaughn kneecap *> netnet.net                                              Neal Cappel kristian.liimatainen ~*}] helsinki.fi                        Lauri Liimatainen lanzyg |= attglobal.net                                          Garrett Lanzy lov2laf [# attglobal.net                                         Robert Tollen lrf $/^& leukaemia.demon.co.uk                                    Ken Campbell mcclenon / erols.com                                              Bob McClenon mclaudi ~[~ totalise.co.uk                                     Dave McLaughlin minhan (=/ pacific.net.sg                                          Tan Min-Han mph -[ astro.caltech.edu                                          Matthew Hunt mtaylor `( lrim.com                                                Mark Taylor nhoffm ~>)= in-kiel.de                                        Norbert Hoffmann olav ,(& viking.mv.com                                         Olav Nieuwejaar qui #_ iobox.fi                                                    jui enquien renate.sch (& gmx.at                                         Renate Schininger richw ($/< webcom.com                                               Rich Wales rick }*) bcm.tmc.edu                                            Richard Miller rockwallaby ]{# erols.com                                       Chris Thompson rridges _= metz.une.edu.au                                      Rebecca Ridges rufinus }>=* mbe.ece.wisc.edu                                        J Rufinus sackv -( uni-duesseldorf.de                                        Victor Sack salazar _[) popd.ix.netcom.com                                    Rick Salazar SESalazar & aol.com                                              Susan Salazar shrao * nyx.net                                                    Shrisha Rao smlucas }&_# famvid.com                                           Steven Lucas speirs =_$ chebucto.ns.ca                                [email protected] tajima {+$ med.teikyo-u.ac.jp                                     Yasuo Tajima tc `/ Mcs.Net                                                      Thomas Cuny teta ] erinet.com                                                 Deborah Marr tgm } netcom.com                                          Thomas G. McWilliams trevort -|*| vianet.on.ca                                       Trevor Tymchuk uthman ,| neosoft.com                                                Ed Uthman vote-8 ) kholdan.snafu.de                                          Tobias Erle wakelyn -/ pinn.net                                              N. T. Wakelyn wiz -]> lart.com                                                    Mike Craig WmHBlair ~$| dnai.com                                         William H. Blair xanthian <<` well.com                                          Kent Paul Dolan  Voted No ------------------------------------------------------------------------------ gprrspw / mindspring.com                                             G.P. Ryan janus +# cwo.com                                                   Keith Adams mantell |$ erols.com                                               Mark Antell naddy /_ mips.rhein-neckar.de                             Christian Weisgerber squid <[{ panix.com                                                   Yeoh Yiu stainles ( bga.com                                                Dwight Brown yan __ storm.ca                                              Yves Bellefeuille  Abstained ------------------------------------------------------------------------------ chris [] kzim.com                                  Christopher Robin Zimmerman james ^+< sfgiants22.freeserve.co.uk                              James Farrar mmontcha & OregonVOS.net                                    Matthew Montchalin peteralf /$] softhome.net                                      Peter Alfredsen philk /<| telerama.com                                           Philip Knight  --  Jim Davis        | "Plaaay NICE!!" [email protected] |   -- Bubbles